Angiogenesis inhibitor improves brain tumor survival by reducing swelling

The beneficial effects of anti-angiogenesis drugs in the treatment of the deadly brain tumors called glioblastomas appear to result primarily from reduction of edema – the swelling of brain tissue – and not from any direct anti-tumor effect, according to a study from Harvard researchers at Massachusetts General Hospital (MGH). read more

Read the whole article on Harvard Science

More from Harvard Science